Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains

Cell Proliferation

Volumn 43, Issue 1, 2010, Pages 29-40

  Zong, F ^a   Fthenou, E ^b   Castro, J ^c   Peterfia B ^d   Kovalszky, I ^d   Szilak L ^e   Tzanakakis, G ^b   Dobra, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CRETE   (Greece)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e UNIVERSITY OF WEST HUNGARY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1;

AMINO ACID SEQUENCE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FUNCTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROSARCOMA; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; HUMANS; MESOTHELIOMA; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SYNDECAN-1; SYNDECAN-2; SYNDECAN-3; SYNDECAN-4; TRANSFECTION;

EID: 73349096615     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00651.x     Document Type: Article

References (43)

1. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729 777.
2. Woods A, Longley RL, Tumova S, Couchman JR (2000) Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch. Biochem. Biophys. 374, 66 72.
3. Yoneda A, Couchman JR (2003) Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 22, 25 33.
4. Chernousov MA, Carey DJ (1993) N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J. Biol. Chem. 268, 16810 16814.
5. Clasper S, Vekemans S, Fiore M, Plebanski M, Wordsworth P, David G et al. (1999) Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 274, 24113 24123.
6. Gotte M (2003) Syndecans in inflammation. FASEB J. 17, 575 591.
7. Mundhenke C, Meyer K, Drew S, Friedl A (2002) Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am. J. Pathol. 160, 185 194.
8. Rapraeger AC (2001) Molecular interactions of syndecans during development. Semin. Cell Dev. Biol. 12, 107 116.
9. Yi JY, Han I, Oh ES (2006) Transmembrane domain-dependent functional oligomerization of syndecans. Scientific World Journal 6, 457 459.
10. Choi S, Lee E, Kwon S, Park H, Yi JY, Kim S et al. (2005) Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J. Biol. Chem. 280, 42573 42579.
11. Asundi VK, Carey DJ (1995) Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region. J. Biol. Chem. 270, 26404 26410.
12. Couchman JR (2003) Syndecans: proteoglycan regulators of cell-surface microdomains? Nat. Rev. Mol. Cell Biol. 4, 926 937.
13. Maday S, Anderson E, Chang HC, Shorter J, Satoh A, Sfakianos J et al. (2008) A PDZ-binding motif controls basolateral targeting of syndecan-1 along the biosynthetic pathway in polarized epithelial cells. Traffic 9, 1915 1924.
14. Fears CY, Woods A (2006) The role of syndecans in disease and wound healing. Matrix Biol. 25, 443 456.
15. Yang Y, Borset M, Langford JK, Sanderson RD (2003) Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface. J. Biol. Chem. 278, 12888 12893.
16. Langford JK, Yang Y, Kieber-Emmons T, Sanderson RD (2005) Identification of an invasion regulatory domain within the core protein of syndecan-1. J. Biol. Chem. 280, 3467 3473.
17. Peterfia B, Hollosi P, Szilak L, Timar F, Paku S, Jeney A et al. (2006) Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma. Magy. Onkol. 50, 115 120.
18. Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R et al. (2009) Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 30, 397 407.
19. Brockstedt U, Dobra K, Nurminen M, Hjerpe A (2002) Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements. Exp. Cell Res. 274, 235 245.
20. Dobra K, Nurminen M, Hjerpe A (2003) Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells. Anticancer Res. 23, 2435 2444.
21. Klominek J, Robert KH, Hjerpe A, Wickstrom B, Gahrton G (1989) Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 49, 6118 6122.
22. Thurzo V, Popovic M, Matoska J, Blasko M, Grofova M, Lizonova A et al. (1976) Human neoplastic cells in tissue culture: two established cell lines derived from giant cell tumor and fibrosarcoma. Neoplasma 23, 577 587.
23. Kalderon D, Roberts BL, Richardson WD, Smith AE (1984) A short amino acid sequence able to specify nuclear location. Cell 39, 499 509.
24. Dingwall C, Laskey RA (1991) Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16, 478 481.
25. Castro J, Heiden T, Wang N, Tribukait B (1993) Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 14, 793 804.
26. Dobra K, Andang M, Syrokou A, Karamanos NK, Hjerpe A (2000) Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp. Cell Res. 258, 12 22.
27. Inki P, Jalkanen M (1996) The role of syndecan-1 in malignancies. Ann. Med. 28, 63 67.
28. Hirabayashi K, Numa F, Suminami Y, Murakami A, Murakami T, Kato H (1998) Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol. 19, 454 463.
29. Choi DS, Kim JH, Ryu HS, Kim HC, Han JH, Lee JS et al. (2007) Syndecan-1, a key regulator of cell viability in endometrial cancer. Int. J. Cancer 121, 741 750.
30. Cortes V, Amigo L, Donoso K, Valencia I, Quinones V, Zanlungo S et al. (2007) Adenovirus-mediated hepatic syndecan-1 overexpression induces hepatocyte proliferation and hyperlipidaemia in mice. Liver Int. 27, 569 581.
31. Leppa S, Mali M, Miettinen HM, Jalkanen M (1992) Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc. Natl. Acad. Sci. USA 89, 932 936.
32. Mali M, Elenius K, Miettinen HM, Jalkanen M (1993) Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J. Biol. Chem. 268, 24215 24222.
33. Numa F, Hirabayashi K, Tsunaga N, Kato H, O'Rourke K, Shao H et al. (1995) Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells. Cancer Res. 55, 4676 4680.
34. Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A et al. (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100, 610 617.
35. Mali M, Andtfolk H, Miettinen HM, Jalkanen M (1994) Suppression of tumor cell growth by syndecan-1 ectodomain. J. Biol. Chem. 269, 27795 27798.
36. Viklund L, Loo BM, Hermonen J, El-Darwish K, Jalkanen M, Salmivirta M (2002) Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein. Biochem. Biophys. Res. Commun. 290, 146 152.
37. Dews IC, Mackenzie KR (2007) Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions. Proc. Natl. Acad. Sci. USA 104, 20782 20787.
38. McQuade KJ, Rapraeger AC (2003) Syndecan-1 transmembrane and extracellular domains have unique and distinct roles in cell spreading. J. Biol. Chem. 278, 46607 46615.
39. Carey DJ, Stahl RC, Tucker B, Bendt KA, Cizmeci-Smith G (1994b) Aggregation-induced association of syndecan-1 with microfilaments mediated by the cytoplasmic domain. Exp. Cell Res. 214, 12 21.
40. Carey DJ, Stahl RC, Cizmeci-Smith G, Asundi VK (1994a) Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J. Cell Biol. 124, 161 170.
41. Gaudin JC, Mehul B, Hughes RC (2000) Nuclear localisation of wild type and mutant galectin-3 in transfected cells. Biol. Cell 92, 49 58.
42. Davidson PJ, Li SY, Lohse AG, Vandergaast R, Verde E, Pearson A et al. (2006) Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import. Glycobiology 16, 602 611.
43. Kato M, Saunders S, Nguyen H, Bernfield M (1995) Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell 6, 559 576.